We thank everyone for their continued support!
MISSING ALL OF YOU
We were so looking forward to coming together for the 10th Anniversary Ruth Farb Golf Classic, to honour Ruth and support a cause very near and dear to us. While we were eager to kick off this milestone year in style, COVID-19 had different plans for all of us this summer.
Although we have to put a pin in this year's festivities, we look forward to joining together and teeing off with an even bigger and better event in 2021. The date of the golf tournament is officially set - and will take place at the Lebovic Golf Club on Wednesday, July 28th, 2021. Mark your calendars!
We can't thank you enough for all of your continued support over the last 10 years! Your participation in this tournament has helped keep Ruth’s memory alive and given hope to families dealing with similar circumstances. Through our partnership with The Canadian Friends of The Hebrew University (CFHU), monies raised has supported ground-breaking collaborative pancreatic cancer research in Ruth's honour in both Canada and Israel.
Next year, a commemorative inscription will be unveiled on Hebrew University’s Wall of Life, highlighting the amazing things we've all done together - and we are grateful for your part in making this possible. The donor recognition wall is located at the southeastern tip of the Mount Scopus campus, overlooking the Old City and West Jerusalem.
Many have asked how they can continue to contribute this year. Firstly, thank you! Secondly, we've provided the link below for those interested in making a donation in 2020 to support Pancreatic Cancer research.
A massive thank you for your continued dedication to an event that means so much to our families. We hope to see you at Lebovic Golf Club in 2021. Enjoy your summer and continue to keep healthy and safe.
Sincerely,
The Farb and Koffman Families
RUTH FARB GOLF CLASSIC THROUGH THE YEARS
THE CAUSE
With thanks to each participant and supporter of the Ruth Farb Golf Tournament, funds raised from the tournament continue to add support to the Alex U Soyka Pancreatic Cancer Research Project, now entering Phase II, with an international network composed of researchers from the Ontario Institute for Cancer Research (OICR), the Hebrew University's Institute for Medical Research Israel-Canada (IMRIC) and Sheba Medical Center in Tel Aviv.
Phase II builds upon the outstanding achievements of Phase I of the Soyka Project by fostering further collaboration between Israeli and Ontario researchers, focusing on three main research avenues in pancreatic cancer – to develop effective patient-specific treatment courses; address the challenges of tumour cell heterogeneity; and create new methods for early-stage diagnosis.
As a measure of its impact so far, Phase I of the Soyka Project has been cited in more than 18 peer-reviewed papers on pancreatic cancer including manuscripts in the prestigious journals Nature Genetics, Nature Medicine and Cancer Cell. Phase II of the Soyka Project will provide eight of Israel’s leading cancer researchers with funds to explore the molecular origins of pancreatic cancer, as well as novel diagnostic biomarkers and therapeutic approaches. These fellowships are key to the multi-disciplinary approach of the Soyka Project and this round of funding will see new scientists joining the team with expertise in single-cell RNA sequencing and bioinformatics, some of the most advanced approaches used in cancer research today.
A central component of Phase II will increase the opportunity for patients at the Sheba Medical Center in Israel to participate in Dr. Steven Gallinger’s OICR-led COMPASS clinical trial, the first time that participation in the study will be offered outside of Canada. COMPASS is a world-leading initiative that uses genomic and transcriptomic information from patient tumours to personalize treatment with the aim of improving outcomes. The data collected through COMPASS will also be used by Soyka Project scientists to further their investigation into the inner workings of pancreatic cancer.
2019 CLASSIC IN REVIEW
